Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
61,463
-
Shares change
-
+54,813
-
Total reported value, excl. options
-
$29,000
-
Value change
-
+$26,000
-
Number of buys
-
2
-
Price
-
$0.5000
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2016
As of 30 Sep 2016 IGC Pharma, Inc. - COM NEW (IGC) had 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 61,463 shares of stock of the company.
Largest 5 holders included PANAGORA ASSET MANAGEMENT INC, UBS Group AG, Creative Planning, Gradient Investments LLC, and LADENBURG THALMANN FINANCIAL SERVICES INC.
This table shows 5 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.